The following is a safe URL to the background of a pharmaceutical company. I need to make sure that I assessed the company correctly, so please answer the two questions that follow. Thanks!

file:///C:/Users/user/Downloads/Angiotech%20Case%20Study.pdf

I know that the target market is the collaborating partners and not doctors and patients since clinical trials are still underway. But who does the market not serve? And who could the market serve even though the clinical trials are still underway? I am assuming that the other stent producers who do not have agreements with Angiotech are the ones not being served and who could be served. Am I right?